- Home
- FLUX vs DARE Comparison
FLUX vs DARE Comparison
Compare FLUX & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- DARE
- Stock Information
- Founded
- FLUX N/A
- DARE 2015
- Country
- FLUX United States
- DARE United States
- Employees
- FLUX N/A
- DARE N/A
- Industry
- FLUX Industrial Machinery/Components
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- FLUX Miscellaneous
- DARE Health Care
- Exchange
- FLUX Nasdaq
- DARE Nasdaq
- Market Cap
- FLUX 25.4M
- DARE 26.3M
- IPO Year
- FLUX N/A
- DARE N/A
- Fundamental
- Price
- FLUX $1.77
- DARE $2.39
- Analyst Decision
- FLUX Strong Buy
- DARE Strong Buy
- Analyst Count
- FLUX 2
- DARE 3
- Target Price
- FLUX $6.00
- DARE $12.50
- AVG Volume (30 Days)
- FLUX 151.9K
- DARE 4.6M
- Earning Date
- FLUX 08-15-2025
- DARE 08-11-2025
- Dividend Yield
- FLUX N/A
- DARE N/A
- EPS Growth
- FLUX N/A
- DARE N/A
- EPS
- FLUX N/A
- DARE N/A
- Revenue
- FLUX $63,074,000.00
- DARE $25,909.00
- Revenue This Year
- FLUX $11.10
- DARE $74,787.57
- Revenue Next Year
- FLUX $12.66
- DARE $141.76
- P/E Ratio
- FLUX N/A
- DARE N/A
- Revenue Growth
- FLUX N/A
- DARE N/A
- 52 Week Low
- FLUX $1.15
- DARE $2.11
- 52 Week High
- FLUX $3.99
- DARE $9.19
- Technical
- Relative Strength Index (RSI)
- FLUX 48.92
- DARE 43.58
- Support Level
- FLUX $1.70
- DARE $2.44
- Resistance Level
- FLUX $2.15
- DARE $2.80
- Average True Range (ATR)
- FLUX 0.19
- DARE 0.66
- MACD
- FLUX -0.04
- DARE 0.01
- Stochastic Oscillator
- FLUX 26.80
- DARE 5.23
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.